About OriGene
OriGene is a company based in Rockville (United States) founded in 1996.. OriGene has raised $69.55 million across 11 funding rounds from investors including Kleiner Perkins, Uni-President and HHS. OriGene has completed 3 acquisitions, including Blue Heron Bio, Marligen Biosciences and biocheckinc.com. OriGene operates in a competitive market with competitors including Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
- Headquarter Rockville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Origene Technologies, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$69.55 M (USD)
in 11 rounds
-
Latest Funding Round
$17.05 M (USD), Series D
Jun 09, 2015
-
Investors
Kleiner Perkins
& 10 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Blue Heron Bio
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of OriGene
OriGene has successfully raised a total of $69.55M across 11 strategic funding rounds. The most recent funding activity was a Series D round of $17.05 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series D — $17.1M
- First Round First Round
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Series D - OriGene | Valuation | Cathay Capital , Merieux Developement |
|
| Mar, 2014 | Amount | Series C - OriGene | Valuation |
investors |
|
| Mar, 2013 | Amount | Series C - OriGene | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OriGene
OriGene has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Uni-President and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cathay Capital is engaged in global investment and transformation.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OriGene
OriGene has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Blue Heron Bio, Marligen Biosciences and biocheckinc.com. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Limited information available
|
2001 | ||||
|
Gene synthesis and sequencing services are provided using proprietary technology.
|
1999 | ||||
|
In-vitro diagnostic kits and research reagents are developed and marketed.
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - OriGene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Origene Comparisons
Competitors of OriGene
OriGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Origene
Frequently Asked Questions about OriGene
When was OriGene founded?
OriGene was founded in 1996 and raised its 1st funding round 8 years after it was founded.
Where is OriGene located?
OriGene is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Is OriGene a funded company?
OriGene is a funded company, having raised a total of $69.55M across 11 funding rounds to date. The company's 1st funding round was a Series C of $21.3M, raised on Sep 23, 2004.
What does OriGene do?
OriGene Technologies is focused on developing proteins, antibodies, and other molecular tools to support the academic, pharmaceutical, and biotech companies in their research of gene functions and drug discovery. Its product lines include the large cDNA and shRNA clone collections, about 5k purified human proteins, monoclonal antibodies (TrueMAB), 140k validated human tissues, and protein microarray products. It also provides a range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from the Companys tissue collection.
Who are the top competitors of OriGene?
OriGene's top competitors include Abcam, Sino Biological and Meridian Bioscience.
How many acquisitions has OriGene made?
OriGene has made 3 acquisitions, including Blue Heron Bio, Marligen Biosciences, and biocheckinc.com.
Who are OriGene's investors?
OriGene has 11 investors. Key investors include Kleiner Perkins, Uni-President, HHS, Qiming Venture Partners, and NHGRI.